References
- Bharali DJ, Siddiqui IA, Adhami VM, et al. Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects. Cancers. 2011;3(4):4024–4045.10.3390/cancers3044024
- Mandalari G, Bennett R, Bisignano G, et al. Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J Appl Microbiol. 2007;103(6):2056–2064.10.1111/jam.2007.103.issue-6
- Tapas AR, Sakarkar D, Kakde R. Flavonoids as nutraceuticals: a review. Trop J Pharm Res. 2008;7(3):1089–1099.
- Gattuso G, Barreca D, Gargiulli C, et al. Flavonoid composition of citrus juices. Molecules. 2007;12(8):1641–1673.10.3390/12081641
- Miller EG, Peacock JJ, Bourland TC, et al. Inhibition of oral carcinogenesis by citrus flavonoids. Nutr Cancer. 2007;60(1):69–74.10.1080/01635580701616163
- Mori A, Nishino C, Enoki N, et al. Cytotoxicity of plant flavonoids against Hela cells. Phytochemistry. 1988;27(4):1017–1020.10.1016/0031-9422(88)80264-4
- Benavente-Garcia O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008;56(15):6185–6205.10.1021/jf8006568
- Spencer JP, Vauzour D, Rendeiro C. Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys. 2009;492(1-2):1–9.10.1016/j.abb.2009.10.003
- Narayana KR, Reddy MS, Chaluvadi M, et al. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential. Indian J Pharmacol. 2001;33(1):2–16.
- Asres K, Seyoum A, Veeresham C, et al. Naturally derived anti-HIV agents. Phytother Res. 2005;19(7):557–581.10.1002/(ISSN)1099-1573
- Cushnie TT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agent. 2005;26(5):343–356.10.1016/j.ijantimicag.2005.09.002
- Benavente-García O, Castillo J, Marin FR, et al. Uses and properties of citrus flavonoids. J Agric Food Chem. 1997;45(12):4505–4515.10.1021/jf970373s
- Tijburg L, Mattern T, Folts J, et al. Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci. 1997;37(8):771–785.10.1080/10408399709527802
- Middleton E, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 1992;43(6):1167–1179.10.1016/0006-2952(92)90489-6
- Bachrach U, Wang Y-C. Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Amino Acids. 2002;22(1):1–13.10.1007/s726-002-8197-9
- Jagtap S, Meganathan K, Wagh V, et al. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem. 2009;16(12):1451–1462.10.2174/092986709787909578
- Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 2011;11(3):211–218.10.1038/nrc3017
- Narayan S. Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting β-catenin-mediated transactivation and cell–cell adhesion pathways. J Mol Histol. 2004;35(3):301–307.
- Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr. 1999;38(3):133–142.10.1007/s003940050054
- Beutler JA, Hamel E, Vlietinck AJ, et al. Structure-activity requirements for flavone cytotoxicity and binding to tubulin. J Med Chem. 1998;41:2333–2338.10.1021/jm970842 h
- Mojzis J, Varinska L, Mojzisova G, et al. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res. 2008;57(4):259–265.10.1016/j.phrs.2008.02.005
- Babu KS, Babu TH, Srinivas P, et al. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. Bioorg Med Chem Lett. 2006;16(1):221–224.10.1016/j.bmcl.2005.09.009
- Yang F, Jin H, Pi J, et al. Anti-tumor activity evaluation of novel chrysin–organogermanium(IV) complex in MCF-7 cells. Bioorg Med Chem Lett. 2013;23(20):5544–5551.10.1016/j.bmcl.2013.08.055
- Zou X-Q, Peng S-M, Hu C-P, et al. Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection. Bioorg Med Chem Lett. 2011;21(4):1222–1226.10.1016/j.bmcl.2010.12.077
- Anand KV, Anandhi R, Pakkiyaraj M, et al. Protective effect of chrysin on carbon tetrachloride (CCl 4 )—induced tissue injury in male Wistar rats. Toxicol Ind Health. 2011;27(10):923–933.10.1177/0748233711399324
- Ciftci O, Ozdemir I. Protective effects of quercetin and chrysin against 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) induced oxidative stress, body wasting and altered cytokine productions in rats. Immunopharmacol Immunotoxicol. 2011;33(3):504–508.10.3109/08923973.2010.543686
- Khan R, Khan AQ, Qamar W, et al. Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol Appl Pharmacol. 2012;258(3):315–329.10.1016/j.taap.2011.11.013
- Lim H, Jin JH, Park H, et al. New synthetic anti-inflammatory chrysin analog, 5,7-dihydroxy-8-(pyridine-4yl)flavone. Eur J Pharmacol. 2011;670(2–3):617–622.10.1016/j.ejphar.2011.09.010
- Khoo BY, Chua SL, Balaram P. Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci. 2010;11(5):2188–2199.10.3390/ijms11052188
- Monasterio A, Urdaci MC, Pinchuk IV, et al. Flavonoids induce apoptosis in human leukemia U937 cells through caspase-and caspase-calpain-dependent pathways. Nutr Cancer. 2004;50(1):90–100.10.1207/s15327914nc5001_12
- Sak K. Characteristic features of cytotoxic activity of flavonoids on human cervical cancer cells. Asian Pac J Cancer Prev. 2014;15(19):8007–8018.10.7314/APJCP.2014.15.19.8007
- Anari E, Akbarzadeh A, Zarghami N. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol. 2016;44(6):1410–1416.
- Vaculikova E, Grunwaldova V, Kral V, et al. Primary investigation of the preparation of nanoparticles by precipitation. Molecules. 2012;17(9):11067–11078.10.3390/molecules170911067
- Ige PP, Baria RK, Gattani SG. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Colloids Surf B. 2013;108:366–373.10.1016/j.colsurfb.2013.02.043
- Thakkar HP, Patel BV, Thakkar SP. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement. J Pharm Bioallied Sci. 2011;3(3):426.10.4103/0975-7406.84459
- Alam N, Qayum A, Kumar A, et al. Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol. Mater Sci Eng C. 2016;68:109–116.10.1016/j.msec.2016.05.093
- Patil PO, Bhandari PV, Deshmukh PK, et al. Green fabrication of graphene-based silver nanocomposites using agro-waste for sensing of heavy metals. Res Chem Intermed. 2017;43(7):3757–3773.10.1007/s11164-016-2844-9
- Zhong L, Yun K. Graphene oxide-modified ZnO particles: synthesis, characterization, and antibacterial properties. Int J Nanomed. 2015;10(Spec Iss):79.
- Abdelhamid HN, Wu H-F. Facile synthesis of nano silver ferrite (AgFeO2) modified with chitosan applied for biothiol separation. Mater Sci Eng C. 2014;45:438–445.10.1016/j.msec.2014.08.071
- Yedurkar S, Maurya C, Mahanwar P. Biosynthesis of zinc oxide manoparticles using Ixora coccinea leaf extract—a green approach. Open J Synth Theory Appl. 2016;5:1–14.
- Masarudin MJ, Cutts SM, Evison BJ, et al. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnol Sci Appl. 2015;8:67.10.2147/NSA
- Ostolska I, Wiśniewska M. Application of the zeta potential measurements to explanation of colloidal Cr2O3 stability mechanism in the presence of the ionic polyamino acids. Colloid Polym Sci. 2014;292(10):2453–2464.10.1007/s00396-014-3276-y
- Meléndrez M, Cárdenas G, Arbiol J. Synthesis and characterization of gallium colloidal nanoparticles. J Colloid Interface Sci. 2010;346(2):279–287.s10.1016/j.jcis.2009.11.069
- Desai PS, Pore YV. Physicochemical characterization of spray dried cefixime polymeric nanoparticles using factorial design approach. J Applied Pharm Sci. 2016;6(2):124–132.10.7324/JAPS
- Kaur H, Singh Malik D, Kaur G. Enhanced dissolution and antioxidant activity of chrysin nanoparticles employing Co-precipitation as a technique. Pharm Nanotechnol. 2015;3(3):205–218.
- Chadha R, Bhalla Y, Nandan A, et al. Chrysin cocrystals: characterization and evaluation. J Pharm Biomed Anal. 2017;134:361–371.10.1016/j.jpba.2016.10.020
- Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. JNCI. J Natl Cancer Inst. 1990;82(13):1107–1112.10.1093/jnci/82.13.1107
- Rajini A, Nookaraju M, Venkatathri N, et al. Synthesis, characterization, antimicrobial and cytotoxic studies of a novel vanadium dodecylamino phosphate. Arab J Chem. 2017;10:S2082–S2089.10.1016/j.arabjc.2013.07.038
- Ghasemi-Kahrizsangi A, Neshati J, Shariatpanahi H, et al. Effect of SDS modification of carbon black nanoparticles on corrosion protection behavior of epoxy nanocomposite coatings. Polym Bull. 2015;72(9):2297–2310.10.1007/s00289-015-1406-4
- Saddow SE. Silicon carbide biotechnology: a biocompatible semiconductor for advanced biomedical devices and applications. Waltham, MA: Elsevier; 2012.
- Whitney W, Noyes A. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930–934.
- Jia L. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches, experimental evidences and theory. Curr Nanosci. 2005;1(3):237–243.10.2174/157341305774642939
- Keepers YP, Pizao PE, Peters GJ, et al. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer Clin Oncol. 1991;27(7):897–900.10.1016/0277-5379(91)90142-Z
- Sabzichi M, Mohammadian J, Bazzaz R, et al. Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway. Process Biochem. 2017;60:84–91.10.1016/j.procbio.2017.05.024
- Inácio ÂS, Mesquita KA, Baptista M, et al. In vitro surfactant structure-toxicity relationships: implications for surfactant use in sexually transmitted infection prophylaxis and contraception. PLoS One. 2011;6(5):e19850.10.1371/journal.pone.0019850
- Bondi CA, Marks JL, Wroblewski LB, et al. Human and environmental toxicity of sodium lauryl sulfate (SLS): evidence for safe use in household cleaning products. Environ Health Insights. 2015;9:27.
- Brito RM, Vaz WL. Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine. Anal Biochem. 1986;152(2):250–255.10.1016/0003-2697(86)90406-9
- Zhang H, Hollis CP, Zhang Q, et al. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm. 2011;415(1–2):293–300.10.1016/j.ijpharm.2011.05.075